The glucagonoma syndrome: Clinical features, diagnosis, and treatment

Endocrine Reviews

Volumn 2, Issue 3, 1981, Pages 347-361

  Stacpoole, Peter W ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUCAGON;

ADULT; BLOOD; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; ECTOPIC HORMONE PRODUCTION; FEMALE; GLUCAGONOMA; HUMAN; HYPERGLYCEMIA; INSULINOMA; MALE; PANCREAS ISLET CELL TUMOR; PANCREAS TUMOR; PATHOLOGY; REVIEW; SKIN;

ADENOMA, ISLET CELL; ADULT; AMINO ACIDS; COMPARATIVE STUDY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLUCAGON; GLUCAGONOMA; HUMAN; HYPERGLYCEMIA; INSULINOMA; MALE; MIDDLE AGE; NEOPLASTIC ENDOCRINE-LIKE SYNDROMES; PANCREATIC NEOPLASMS; SKIN;

EID: 0019578234     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/edrv-2-3-347     Document Type: Article

References (140)

1. Fabozzi S 1903 Ueber die Histogenese des primären Drebses des Pankreas. Beitr Pathol Anat 34:199
2. Wilder RM, Allan FN, Power MH, Robertson HE 1927 Carcinoma of the islands of the pancreas. J Am Med Assoc 89:348
3. Becker SW, Kahn D, Rothman S 1942 Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syphilol 45:1069
4. Hamperl H 1952 Über argyrophile Zellen. Virchows Arch 321:482
5. Zhdanov VS 1956 Diabetes in a case of tumors of the islets of the pancreas. Arch Pathol (Moscow) 18:92
6. Gössner OW, Körting GW 1960 Metastasierendes Inselzell-Karzinom vom A-Zelltyp bei einem Fall von Pemphigus foliaceus mit Diabetes renalis. Dtsch Med Wochenschr 85:434
7. Behrendt W 1963 Ein Beitrag zur Pathologie des A-Zellkarzinoms. Zentralb AUg Pathol Pathol Anat 104:199
8. Keen H 1962 Fluctuating hyper-and hypo-glycemia associated with multiple hepatic tumours. Guy’s Hosp Rep 111:200
9. Unger RH, Eisentraut AM, Lochner JdeV 1963 Glucagon-producing tumors of the islets of Langerhans. J Clin Invest 42:987
10. Yoshinaga T, Okuno G, Shinji Y, Tsujii T, Nishikawa M 1966 Pancreatic A-cell tumor associated with diabetes mellitus. Diabetes 15:709
11. McGavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME 1966 A glucagon-secreting a-cell carcinoma of the pancreas. N Engl J Med 274:1408
12. Church RE, Crane WAJ 1967 A cutaneous syndrome associated with islet-cell carcinoma of the pancreas. Br J Dermatol 79:284
13. Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B 1974 A glucagonoma syndrome. Lancet 2:1
14. Wilkinson DS 1973 Necrolytic migratory erythema with carcinoma of the pancreas. Trans St. Johns Hosp Dermatol Soc 59:244
15. Riddle MC, Golper TA, Fletcher WS, Ensinck JW, Smith PH 1978 Glucagonoma syndrome in a 19-year-old woman. West J Med 129:68
16. Valverde I, Lemon HM, Kessinger A, Unger RH 1976 Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma. J Clin Endocrinol Metab 42:804
17. Valverde I, Villanueva ML, Lozano I, Marco J 1974 Presence of glucagon immunoreactivity in the globulin fraction of human plasma (“big plasma glucagon”). J Clin Endocrinol Metab 39:1090
18. Weir GC, Horton ES, Aoki TT, Slovik D, Jaspan J, Rubenstein AH 1977 Secretion by glucagonomas of a possible glucagon precursor. J Clin Invest 59:325
19. Croughs RJM, Hulsmans HAM, Israël DE, Hackeng WHZ, Schop-men W 1977 Glucagonoma as part of the polyglandular adenoma syndrome. Am J Med 52:690
20. Stacpoole PW, Jaspan J, Kasselberg AG, Halter S, Polonsky K, Gluck F, Liljenquist J, Rabin D 1981 A familial glucagonoma syndrome: genetic, clinical and biochemical features. Am J Med 70:1017
21. Croisier J-C, Croisier G, Schaison G 1973 Les proliférations insulaires pancréatiques associées. Actual Endocrinol (Paris) 13:15
22. Croisier J-C, Lehy T, Zeitoun P 1971 A2 cell pancreatic microadenomas in a case of multiple endocrine adenomatosis. Cancer 28: 707
23. Greider MH, Rosai J, McGuigan JE 1974 The human pancreatic islet cells and their tumors. Cancer 33:1423
24. Gremelius L, Peterson B, Lundquist G, Dahlgren S, Parrow A 1971 Staining reactions in an islet cell carcinoma of «2-type. Acta Soc Med Upsal 76:49
25. Jones RA, Dawson IMP 1977 Morphology and staining patterns of endocrine cell tumors in the gut, pancreas and bronchus and their possible significance. Histopathology 1:137
26. Largiadèr F 1977 Endokrin aktive Pankreasgeschwülste: Helv Chir Acta 44:747
27. Larsson L-I, Grimelius L, Hakanson R, Rehfeld JF, Stadil F, Holst J, Angervall L, Sundler F 1975 Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol 79:271
28. Lomskÿ R, Langer F, Vortel V 1969 Demonstration of glucagon in islet cell adenomas of the pancreas by immunofluorescent technique. Am J Clin Pathol 51:245
29. O’Neal, Kipnis DM, Luse SA, Lacy PE, Jarett L 1968 Secretion of various endocrine substances by ACTH-secreting tumors—gastrin, melanotropin, norepinephrine, serotonin, parathormone, vasopressin, glucagon. Cancer 21:1219
30. Unger RH, Lochner JdeV, Eisentraut AM 1964 Identification of insulin and glucagon in a brochogenic metastasis. J Clin Endocrinol 24:823
31. Vance JE, Stoll RW, Kitabchi AE, Williams RH, Wood Jr FC 1969 Nesidioblastosis in familial endocrine adenomatosis. J Am Med Assoc 207:1679
32. Leclere J, Vicarie F, Laurent J, Jeanpierre R, Floquet J, Grignon G, Hartemann P 1977 Tumeur insulaire avec diarrhiée et diabete (glucagonome?) associée à un hyperparthyroidisme. Actual Endocrinol (Paris) 38:153
33. Leichter SB, Pagliara AS, Greider MH, Pohl S, Rosai J, Kipnis DM 1975 Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma. Am J Med 58:285
34. Tiengo A, Fedele D, Marchiori E, Nosadini R, Muggeo M 1976 Suppression and stimulation mechanisms controlling glucagon secretion in a case of islet-cell tumor producing glucagon, insulin, and gastrin. Diabetes 25:408
35. Boden G, Owen OE 1977 Familial hyperglucagonemia—an autosomal dominant disorder. N Engl J Med 296:534
36. Jaspan JB, Rubenstein AH 1977 Circulating glucagon. Diabetes 26:887
37. Warin AP 1974 Necrolytic migratory erythema with glucagon-secreting tumour of the pancreas. Proc R Soc Med 67:1008
38. Day JL, Anderson J 1973 Abnormalities of glucagon metabolism in diabetes mellitus. Clin Endocrinol 2:211
39. Müller WA, Faloona GR, Aguilar-Parada E, Unger RH 1970 Abnormal alpha-cell function in diabetes. N Engl J Med 283:109
40. Raskin P, Unger RH 1978 Hyperglucagonemia and its suppression. N Engl J Med 299:433
41. Unger RH, Aguilar-Parada E, Müller WA, Eisentraut AM 1970 Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 49:837
42. Donowitz M, Hendler R, Sprio HM, Binder HJ, Felig P 1975 Glucagon secretion in acute and chronic pancreatitis. Ann Intern Med 83:778
43. Goodenberger DM, Lawley TJ, Strober W, Wyatt L, Sangree MH, Sherwin R, Rosenbaum H, Braverman I, Katz SI 1979 Necrolytic migratory erythema without glucagonoma. Arch Dermatol 115: 1429
44. Doyle JA, Schroeter AL, Rodgers RS 1979 Hyperglucagonemia and necrolytic migratory erythema in cirrhosis—possible pseudo-glucagonoma syndrome. Br J Dermatol 100:581
45. Sherwin R, Joshi P, Hendler R, Felig P, Conn HO 1974 Hyperglucagonemia in Laennec’s cirrhosis. N Engl J Med 290:239
46. Shurberg JL, Ross E, Resnick RH, Koff RS, Weir GC, Pallotta J 1976 Serum lipids, insulin and glucagon after portacaval shunt in cirrhosis. Gastroenterology 70:937
47. Rocha RM, Santeusanio F, Faloona GR, Unger RH 1973 Abnormal pancreatic alpha-cell function in bacterial infections. N Engl J Med 288:700
48. Giddings AEB, O’Connor KJ, Rolands BJ, Mangnall D, Clark RG 1976 The relationship of plasma glucagon to the hyperglycemia and hyperinsulinaemia of surgical operation. Br J Surg 63:612
49. Lindsey A, Santeusanio F, Braaten J, Faloona GR, Unger RH 1974 Pancreatic alpha-cell function in trauma. J Am Med Assoc 227:757
50. Berger M, Teuscher A, Halbaw P, Trimble E, Studer PP, Wollheim CB, Zimmermann-Telschow H, Miiller WA 1980 In vitro and in vivo studies on glucagonoma tissue. Horm Metab Res 12:144
51. Danforth DN, Triche T, Doppman JL, Beazley RM, Perrino P, Recant L 1976 Elevated plasma proglucagon-like component with a glucagon-secreting tumor. N Engl J Med 295:242
52. Krebs A, Teuscher A, Armagni C 1978 Syndrome de glucagonome: manifestations cutanées. Ann Dermatol Venereol (Paris) 105:637
53. Recant L, Perrino PV, Bhathena SJ, Danforth DN, Lavine RL 1976 Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased “large” glucagon-immunoreactivity. Dia-betologia 12:319
54. Walter RM, Dudl RJ, Ensinck JW 1972 Immunoreactive glucagon in islet cell tumors. Diabetes [Suppl 1] 21:333
55. Youker GD, Riddle MC 1980 High big plasma glucagon (BPG) in a glucagonoma patient’s family. Clin Res 28:55A
56. Marliss EB, Aoki, Unger RH, Soeldner JS, Cahill Jr GF 1970 Glucagon levels and metabolic effects in fasting man. J Clin Invest 49:2256
57. Unger RH 1971 Glucagon physiology and pathophysiology. N Engl J Med 285:443
58. Iverson J 1971 Adrenergic receptors for the secretion of immunoreactive glucagon and insulin from the isolated perfused canine pancreas. Diabetologia 7:485
59. Strauss GM, Weitzman SA, Aoki TT 1979 Dimethyltriazenoimi-dazole carboxamide therapy of malignant glucagonoma. Ann Intern Med 90:57
60. Swenson KH, Amon RB, Hanifïn JM 1978 The glucagonoma syndrome. Arch Dermatol 114:224
61. Buchanan KD, Vance JE, Williams RH 1969 Insulin and glucagon release from isolated islets of Langerhans. Diabetes 18:381
62. Iverson J 1971 Secretion of glucagon from the isolated, perfused canine pancreas. J Clin Invest 50:2123
63. Ohneda A, Sato M, Matsuda K, Yanke A, Maruhama Y, Yamagata S 1972 Plasma glucagon response to blood glucose fall, gastrointestinal hormones and arginine in man. Tohoku J Exp Med 107: 241
64. Williams RH, Champagne J 1979 Effects of cholecystokinin, secretin and pancreatic polypeptide on secretion of gastric inhibitory polypeptide, insulin and glucagon. Life Sci 25:947
65. Binnick AM, Spencer SK, Dennison Jr WL, Horton ES 1977 Glucagonoma syndrome. Arch Dermatol 113:749
66. Heynan GO, Luyckx A, Franchimont P, van Cauwenberge H 1973 La regulations des sécrétions endocriniennes dans un cas de po-lyadénomatose. Actual Endocrinol (Paris) 13:275
67. Ohneda A, Otsuki M, Fujiya H, Yaginuma N, Kokubo T, Ohtani H 1979 A malignant insulinoma transformed into a glucagonoma syndrome. Diabetes 28:962
68. Stevens FM, Flannagan RWJ, Buchanan KD, O’Gorman DJ 1977 The First Irish glucagonoma. Ir J Med Sci 146:350
69. Orci L, Unger RH 1975 Functional subdivision of islets of Langerhans and possible role of D Cells. Lancet 2:1243
70. Weir GC, Horton ES, Aoki TT, Slovik DM 1976 Increased circulating large glucagon immunoreactivity in the glucagonoma syndrome. Diabetes [Suppl 1] 25:326
71. Soler NG, Oates GD, Malins JM 1976 Glucagonoma syndrome in a young man. Proc R Soc Med 89:429
72. Auerbach RC, Koehler PR 1973 The many faces of islet cell tumors. Am J Roentgenol 119:133
73. Bordi C, Ravazzola M, Baetens D, Gorden P, Unger RH, Orci L 1979 A study of glucagonomas by light and electron microscopy and immunofluorescence. Diabetes 28:925
74. Ingemannson S, Lunderquist A, Holst J 1976 Selective catheriza-tion of the pancreatic vein for radioimmunoassay in glucagon-secreting carcinoma of the pancreas. Radiology 119:555
75. Ingemannson S, Holst J, Larson L-I, Lunderquist A 1977 Localization of glucagonomas by catherization of the pancreatic veins and with glucagon assay. Surg Gynecol Obstet 145:509
76. McGavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin M 1966 A glucagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med 274:1408
77. Montenegro F, Lawrence GD, Macon W, Pass C 1980 Metastatic glucagonoma. Improvement after surgical debulking. Am J Surg 139:424
78. Röckl H, Metz J, Ackermann-Schopf C 1977 Staphylodermia superficialis circinata. Hautarzt 28:178
79. Shupack JL, Berczeller PH, Stephens DM 1978 The glucagonoma syndrome. J Dermatol Surg Oncol 4:242
80. Teuseher A, Studer PP, Kreks A, Berger M, Aeberhard P 1979 Diabetesverlauf und Klinisches Bild bei glukagonom. Schweiz Med Wochenschr 109:1273
81. Cho KJ, Wilcox CW, Reuter SR 1977 Glucagon-producing islet cell tumor of the pancreas. AJR 129:159
82. Stumer WQ 1972 Sudden death from non-insulin secreting islet cell tumor of the pancreas (“glucagonoma”). Hum Pathol 3:113
83. Beltzer-Garelli E, Cesarini JP, Cywinder-Golenzer Ch, Eskenazi A, Grupper Ch 1979 Lésions cutanées révélatrices d’un glucagonome. Arch Anat Cytol Pathol 27:163
84. Case Records of the Massachusetts General Hospital. N Engl J Med 292:1117
85. Friesen SR, Hermreck AS, Mantz Jr FA 1974 Glucagon, gastrin, and carcinoid tumors of the duodenum, pancreas, and stomach: polypeptide “apudomas” of the foregut. Am J Surg 127:90
86. Hoitsma H, Cuesta MA, Starink ThM, Uttendorfsky-van der Putten HJCM, Van der veen EA 1979 Zinc deficiency syndrome verses glucagonoma syndrome. Arch Chir Neerl 31:131
87. Pederson NB, Jonsson L, Holst JJ 1976 Necrolytic migratory erythema and glucagon cell tumor of the pancreas: the glucagonoma syndrome. Acta Derm Venereol (Stockh) 56:391
88. Higgins GA, Recant L, Fischman AB 1979 The glucagonoma syndrome: surgically curable diabetes. Am J Surg 137:142
89. Kahan RS, Perez-Figaredo RA, Neimanis A 1977 Necrolytic migratory erythema. Arch Dermatol 113:792
90. Stanley RJ, Leichter S 1975 Pancreatic glucagonoma: a clinical-angiographic correlation. Mo Med 72:134
91. Cassano C, Andreani D, Menzinger G, Fallucca F, Tamburrano G 1973 Adénomes pancrétiques et pathologie polyendocrinierine. Actual Endocrinol (Paris) 13:29
92. Hawkins JR, Caude JV 1976 Angiographie findings in some rare pancreatic tumors. Fortschr Röntgenstr 125:521
93. Lightman SL, Bloom SR 1974 Cure of insulin-dependent diabetes mellitus by removal of a glucagonoma. Br Med J 1:367
94. Roggli VL, Judge DM, McGavran MH 1979 Duodenal glucagonoma: a case report. Hum Pathol 10:350
95. Gleeson MH, Bloom SR, Polak JM, Henry K, Dowling RH 1971 Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gut 12:773
96. Bloom SR 1972 An enteroglucagon tumour. Gut 13:520
97. Tager HS, Markese J 1979 Intestinal and pancreatic glucagon-like peptides. J Biol Chem 254:2229
98. Heilman B 1959 The frequency distribution of the number and volume of the islets of Langerhans in man. Acta Soc Med Upsal 64:432
99. Dawson IMP 1976 The endocrine cells of the gastro-intestinal tract and the neoplasms which arise from them. Curr Topics Pathol 63:222
100. Larsson L-I 1978 endocrine pancreatic tumors. Hum Pathol 9:401
101. Martin ED, Potet F 1974 Pathology of endocrine tumours of the GI tract. Clin Gastroenterol 3:511
102. Baum J, Simons BE, Unger RH, Madison LL 1962 Localization of glucagon in the alpha cells in the pancreatic islets by immunoflu-orescent techniques. Diabetes 11:371
103. Unger RH, Eisentraut AM, McCall MS, Keller S, Lanz HC, Madison LL 1959 Glucagon antibodies and their use for immunoassay for glucagon. Proc Soc Exp Biol Med 102:621
104. Kessinger A, Lemon HM, Foley JF 1977 The glucagonoma syndrome and its management. J Surg Oncol 9:419
105. Boden G, Owen OE, Rezvani I, Elfenbein BI, Quickel KE 1977 An islet cell carcinoma containing glucagon and insulin. Diabetes 26: 128
106. Huseby RA, Sussman KE, McGavran MH 1968 A glucagon-secreting islet cell carcinoma. Diabetes [Suppl 1] 17:327
107. Khandekar JD, Oyer D, Miller HJ, Vick NA 1979 Neurologic involvement in glucagonoma syndromes. Cancer 44:2014
108. Moody AJ, Jacobsen H, Sundvy F, Frandsen EK, Baetens D, Orci L 1977 Heterogeneity of gut glucagon-like immunoreactivity (GLI). In: Foà PP, Bajaj JS, Foâ NL (eds) Glucagon: Its Role in Physiology and Clinical Medicine. Springer Verlag, Berlin, p 129
109. Sohier J, Jeanmougan M, Lombrail P, Passa Ph 1980 Rapid improvement of skin lesions in glucagonomas with intravenous somatostatin infusion. Lancet 1:40
110. Liljenquist LE, Bloomgarden ZT, Cherrington AD, Perry JM, Rabin D 1979 Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulino-puenia in man. Diabetologia 17:139
111. Liljenquist JE, Chiasson JL, Cherrington AD, Keller U, Jennings AS, Bomboy JE, Lacy WW 1976 An important role for glucagon in the regulation of glucose production in vivo. Metabolism 25: 1371
112. Liljenquist JE, Mueller GL, Cherrington AD, Keller U, Chiasson JL, Perry JM, Lacy WW, Rabinowitz D 1977 Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest 59:369
113. Sherwin RS, Fisher M, Hendler R, Felig P 1976 Hyperglucago-nemia and blood glucose regulation in normal, obese and diabetic subjects. N Engl J Med 294:455
114. Cherrington AD, Lacy WW, Chiasson J-L 1978 Effect of glucagon on glucose production during insulin deficiency in the dog. J Clin Invest 62:664
115. Holst JJ, Hellan S, Ingemannson S, Pederson NB, von Schenck H 1979 Functional studies in patients with the glucagonoma syndrome. Diabetologia 17:151
116. Long RG, Adrian TE, Brown MR, Rivier JE, Barnes AJ, Mallinson CN, Vale W, Christofides ND, Bloom SR 1979 Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet 2:764
117. Boden G, Wilson RM, Owen OE 1978 Effects of chronic glucagon excess on hepatic metabolism. Diabetes 27:643
118. McGarry JD, Robles-Valdes C, Foster DW 1976 Glucagon and ketogenesis. Metabolism 25:1387
119. Horton ES, Beisswenger PJ, Aoki TT 1978 Glucose homeostasis in the glucagonoma syndrome. Diabetes [Suppl 2] 27:482
120. Amon RB, Swenson KH, Hanifin JM, Hambidge KM 1976 The glucagonoma syndrome (necrolytic migratory erythema) and zinc. N Engl J Med 295:962
121. Sweet RD 1974 A dermatosis specifically associated with a tumour of pancreatic alpha cells. Br J Dermatol 90:301
122. Sibrack LA, Gonterman IH 1978 Cutaneous manifestations of pancreatic diseases. Cutis 21:763
123. Andreev VC 1978 Skin manifestations in visceral cancer. Curr Probl Dermatol 8:10
124. Mallinson CN, Salmon PR, Borrowman J, Bloom S 1973 The association of a specific skin lesion with islet-cell tumours of the pancreas. Gut 14:827
125. Barber SG, Hamer JD 1976 Skin rash in patient receiving glucagon. Lancet 2:1138
126. Norton JA, Kahn CR, Schiebinger R, Gorschboth C, Brennan MF 1979 Amino acid deficiency and the skin rash associated with glucagonoma. Ann Intern Med 91:213
127. Fitzpatrick GF, Meguid MM, Gitlitz PH, Brennan MF 1977 Glucagon infusion in normal man: effects on 3-methylhistidine excretion and plasma amino acids. Metabolism 26:477
128. Le Cam A, Freychet P 1976 Glucagon stimulates the A system for neutral amino acid transport in isolated hepatocytes of adult rat. Biochem Biophys Res Commun 72:893
129. Mallette LE, Exton JE, Park CR 1969 Effects of glucagon on amino acid transport and utilization in the perfused rat liver. J Biol Chem 244:5724
130. Boden G, Rezvani I, Master RW, Trapp V, Schwartz M, Owen OE 1979 Glucagon deficiency causes hyperaminoacidemia. Clin Res 27:482A
131. Sack Jr GH, Levin J, Bell WR 1977 Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine 56:1
132. Dreiling DA, Janowitz HD 1959 The effect of glucagon on gastric secretion in man. Gastroenterology 36:580
133. Lawrence AM 1969 Glucagon. Annu Rev Med 20:109
134. Kock NG, Darle N, Dotevall G 1967 Inhibition of intestinal motility in man by glucagon given intraportally. Gastroenterology 53:88
135. Polak JM, Adrian RE, Bryant MG, Bloom SR, Heitz P, Pearse AGE 1976 Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet 1:328
136. Service FJ, Dale AJD, Elveback LR, Jiang NS 1976 Insulinoma. Mayo Clin Proc 51:417
137. Stefanini P, Carboni M, Patrassi N, Basoli A 1974 Beta-islet cell tumors of the pancreas: results of a study of 1,067 cases. Surgery 75:597
138. Clarke M, Crofford OB, Graves HA, Scott Jr HW 1972 Functioning beta cell tumors (insulinomas) of the pancreas. Ann Surg 175:956
139. Marynich SP, Fagadau WR, Duncan LW 1980 Malignant glucagonoma syndrome: response to chemotherapy. Ann Intern Med 93:453
140. Miller RE, Horton ES 1979 Neural release of glucagon is inhibited by hyperglycemia and enhanced by phentolamine. Diabetes 28: 762